Back to mobile site

Stifel Reiterates Buy Rating on Rapid Micro Biosystems Inc (RPID) following Q4 report

March 16, 2026 8:58 AM EDT Send to a Friend
Stifel analyst Daniel Arias reiterated a Buy rating and $8.00 price target on Rapid Micro Biosystems Inc (NASDAQ: RPID)The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login